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 ABSTRACT 
GABAB receptor (GABABR)-mediated presynaptic inhibition regulates neurotransmitter release 
from synaptic terminals. In the neonatal hippocampus, GABABR activation reduces GABA release 
and terminates spontaneous network discharges called Giant Depolarising Potentials (GDPs). 
Blocking GABABRs transforms GDPs into longer epileptiform discharges. Thus, GABABR-mediated 
presynaptic inhibition of GABA release (GABA auto-inhibition) controls both spontaneous network 
activity and excitability in the developing hippocampus. 
Here we show that extensive release of endogenous GABA during epileptiform activity impairs 
GABA auto-inhibition, but not GABABR-mediated inhibition of glutamate release, leading to 
hyperexcitability of the neonatal hippocampal network. Paired-pulse depression of GABA release 
(PPD) and heterosynaptic depression of glutamate release were used to monitor the efficacy of 
presynaptic GABABRs-mediated inhibition in slices. PPD, but not heterosynaptic depression, was 
dramatically reduced after potassium (K)-induced ictal-like discharges (ILDs), suggesting a selective 
impairment of GABABR-dependent presynaptic inhibition of GABAergic terminals. Impairing GABA 
auto-inhibition induced a 44% increase in GDP width and the appearance of pathological network 
discharges. Preventing GABA-induced activation of GABABRs during ILDs avoided PPD loss and 
most modifications of the network activity. In contrast, a partial block of GABABRs induced network 
discharges strikingly similar to those observed after K-driven ILDs. Finally, neither loss of GABA 
auto-inhibition nor network hyperexcitability could be observed following synchronous release of 
endogenous GABA in physiological conditions (during GDPs at 1 Hz). Thus, epileptiform activity 
was instrumental to impair GABABR-dependent presynaptic inhibition of GABAergic terminals. 
In conclusion, our results indicate that endogenous GABA released during epileptiform activity can 
reduce GABA auto-inhibition and trigger pathological network discharges in the newborn rat 
hippocampus. Such functional impairment may play a role in acute post-seizure plasticity. 
 
INTRODUCTION  
The occurrence of seizures during development strongly increases the probability of developing 
chronic epilepsy at adult age (Holmes & Ben-Ari, 1998). This suggests that plastic changes occurring 
during and after seizures underlay subsequent remodelling. Ictal discharges are stereotyped epileptic 
events involving the synchronous activation of thousands of neurons in the cortex and hippocampus. 
Long-term changes associated with ictal activity have been thoroughly characterised in the developing 
brain, and include neuronal hyperexcitability (Villeneuve et al., 2000;Bender et al., 2003), 
glutamatergic axonal sprouting (Bender et al., 2003;Holmes et al., 1998) and modifications of 
ionotropic γ-aminobutyric acid (GABA)-receptor mediated synaptic transmission (Chen et al., 
1999;Khalilov et al., 2003). Impaired GABAB receptor (GABABR)-mediated signalling has been 
observed after epileptic activity in the adult hippocampus (Mangan & Lothman, 1996;Haas et al., 
1996;Chandler et al., 2003;Wu & Leung, 1997). In the developing hippocampus, however, it is not 
clear whether GABABR-mediated signalling is functional after seizures. 
GABABRs play a crucial role in controlling the physiological activity of the immature hippocampal 
network. GABAA currents, which mediate most of the inhibitory drive in the adult, are excitatory 
during the first postnatal week of life (Cherubini et al., 1991). Consequently, the synchronous 
activation of hippocampal interneurons results in excitatory network discharges called Giant 
Depolarising Potentials (GDPs) (Ben-Ari et al., 1989). In these peculiar conditions, GABABR 
activation is essential to limit network excitability. Endogenous GABA released during GDPs 
activates GABABRs, thus reducing further GABA release from interneurons and leading to GDP 
termination (McLean et al., 1996). Consistent with this, the pharmacological block of GABABRs 
progressively increases GDP width, transforming GDPs into epileptiform discharges (McLean et al., 
1996;Tosetti et al., 2004). Similar effects can also be observed after the functional impairment of 
GABABR-mediated presynaptic inhibition of GABA release (GABA auto-inhibition) by a prolonged 
application of baclofen, a selective GABABR agonist (Tosetti et al., 2004). This observation raises the 
interesting possibility that a sustained release of endogenous GABA may trigger a functional loss of 
GABA auto-inhibition, leading to hyperexcitability and pathological network activity. Ictal discharges, 
during which both GABA and glutamate are continuously released for several seconds (Velazquez & 
Carlen, 1999;Kohling et al., 2000;Rutecki et al., 1985), are one possible context for such loss to occur.  
Here we report that extensive endogenous GABA release during ictal-like discharges impairs 
GABA auto-inhibition in the newborn rat hippocampus. Such impairment contributes to the network 
hyperexcitability observed following the epileptiform discharges. These data thus reveal a novel role 
of GABABR-mediated signalling in acute post-seizure plasticity of the developing hippocampus. 
 
 
 METHODS 
Tissue preparation 
Brains were removed from anesthetised (350 mg kg-1 chloral hydrate intraperitoneally) male Wistar 
rats (postnatal day 2-5) and immersed into ice cold (2-4°C) artificial cerebrospinal fluid (ACSF) of the 
following composition (mM): NaCl, 126; KCl, 3.5; CaCl2, 2; MgCl2, 1.3; NaH2PO4, 1.2; NaHCO3, 25; 
and glucose, 11; pH 7.4, when equilibrated with 95% O2 and 5% CO2. All animal experiments were 
carried out in accordance with the European Communities Council Directive of 24 November 1986 
(86/609/EEC). Intact hippocampal formations (IHFs) were dissected out as previously described 
(Khalilov et al., 1997), and incubated in oxygenated ACSF at room temperature. When needed, 600 
µm slices were prepared from IHFs using a McIlwain tissue chopper. Both intact IHFs and slices were 
equilibrated at room temperature in oxygenated ACSF for at least 60 min prior to electrophysiological 
recordings. 
 
Recording solutions 
ACSF, the extracellular recording solution, was prepared from a 10 X stock solution immediately 
before the experiment, equilibrated with 95% O2 and 5% CO2, heated at 34°C, and delivered to the 
recording chamber via a pressurised system at a flow rate of 3 ml min-1 (slices), or 10 ml min-1  (IHF).  
For whole-cell recordings from hippocampal slices, intracellular solution contained (in mM): 150 
CsCl2, 2 MgCl2, 0.1 CaCl2, 1 EGTA, 2.5 Na2ATP, 0.4 Na2-GTP, 1.5 Mg-ATP, 10 HEPES, pH=7.25, 
2QX314, osmolarity=275 mOsmol. In these ionic conditions, both ionotropic GABAergic and 
glutamatergic currents reversed around 0 mV. For patch-clamp recordings of the IHF, the intracellular 
solution contained (in mM): 120 CsGluconate, 13.4 CsCl, 10 HEPES, 1.1 EGTA, 0.1 CaCl2, 0.4 
Na2GTP, 4 MgATP, pH=7.4. In these ionic conditions, GABAA currents reversed around –50 mV, 
while ionotropic glutamatergic currents reversed around +10 mV. For all patch-clamp experiments, 
5,6-tetramethylrhodamine biocytin (rhodamine) was dissolved (0.5-1%) in the internal solution to 
allow post-hoc visualisation of the recorded neurons. For extracellular field recordings, pipettes were 
filled with ACSF. 
 
Electrophysiological recordings  
CA3 pyramidal neurons were recorded from either hippocampal slices or IHFs (Khalilov et al., 
1997). Spontaneous and evoked synaptic activities were acquired with an Axopatch 2B patch-clamp 
amplifier (Axon Instruments, USA), filtered at 10 kHz, digitised using a Digidata 1200 A/D interface 
(Axon Instruments, USA) and stored on a Pentium II 450 MHz PC running Axoscope 8.1 (Axon 
Instruments, USA) for off-line analysis. Field potentials were recorded using a DAM80 Amplifier 
(World Precision Instruments, USA) using a 1 to 3 Hz band pass filter. Capacitance, input and series 
resistances were measured online with Acquis Software (Biologic, France). Patch-clamp pipettes had a 
resistance of 3 to 5 MΩ, once filled with the internal recording solution. Series resistances ranged 
from 15 to 30 MΩ. Cells showing series resistances > 30 MΩ were discarded. Field recordings were 
preformed with glass micropipettes of 10-20 MΩ resistance. To reserve the viability of the IHF 
preparation and avoid ischemic artefacts, each IHF was recorded for no more than to 2 hrs. 
 
Impairment of GABA auto-inhibition 
In both hippocampal slices and IHFs, functional impairment of GABA auto-inhibition was induced 
via ictal-like discharge (ILD)-promoted sustained release of endogenous GABA (Fig 1A). ILDs were 
triggered by the bath application (9.1±0.9 min, range 8-10 min) of 8.5 to 10 mM K+. When either 500 
µM CGP35348 or 10 µM CNQX + 40 µM APV were co-applied with high K, the cumulative 
discharge time was monitored to guarantee GABA release consistency among pharmacologically 
distinct induction phases. In high K, ILDs represented 41±3% of the overall induction duration. In 
high K + CGP35348, the ILD contribution was not significantly different (39±2%, P>0.1), although 
the presence of CGP35348 slightly shortened the ILD duration (high K: 90±5 s, n=30; high K + 
CGP35348: 76±3 s, n=12, P<0.05) and increased their frequency (high K: 4.1±0.1 mHz; high K + 
CGP35348: 5.6±0.2 mHz; P<0.01). In high K + CNQX + APV, ILDs were not present, but GABA 
was still released via short, frequent bursts that constituted 63±4% of the induction phase. When ILDs 
were induced by 500 µM CGP35348 alone, they represented 44±5% of the induction phase. 
 
Data analysis 
All recordings were visualised using Axoclamp 8.1 software (Axon Instruments, USA), and 
analysed using the Acquis (Biologic, France), Minianalysis (Synaptosoft, USA) and Igor software 
(Wavemetrics, USA).  
Paired pulse depression (PPD) of GABAergic synapses impinging onto CA3 pyramidal neurons 
was measured using pairs of identical stimuli (4-15 V, 0.03 ms each) at 250-350 ms interval, delivered 
at a frequency of 0.03 Hz with a bipolar tungsten electrode placed in the CA3 stratum radiatum. The 
resulting pairs of postsynaptic GABAA currents (GABAA-PSCs) were isolated in the presence of 10 
µM CNQX and 40 µM D-APV. PPD was measured from the amplitude difference between the 1st and 
2nd GABAA-PSCs, normalised to the amplitude of the 1st GABAA-PSC. Average PPD values were 
calculated from 15 paired stimulations delivered at 0.03 Hz starting either 15 min before (control 
PPD) or 5 min after the different pharmacological treatments. For baclofen experiments, a 10 min 
ACSF wash was introduced between the end of the baclofen treatment and the restarting of the PPD 
stimulations, to allow a thorough washout of the drug. Cells showing differences in the amplitude of 
the 1st GABAA-PSC before and after treatment were discarded.  
Heterosynaptic depression of glutamatergic synapses impinging on CA3 pyramidal neurons was 
measured by stimulating two independent glutamatergic pathways via two stimulating electrodes 
positioned in the stratum radiatum on opposite sides of the recording electrode. The electrode position 
and stimulus intensity were optimized for maximal field EPSP (fEPSP) amplitude. Stimulated 
pathways were tested for independence by verifying the absence of cross-facilitation. To induce 
heterosynaptic depression, a single stimulus was given to the 1st pathway (unconditioned fEPSP). 
After 30 sec, an identical stimulus was given to the same pathway, immediately (300 ms) preceded by 
a conditioning train (10 stimuli at 50 Hz) to the 2nd pathway. This originated a conditioned fEPSP. The 
magnitude of heterosynaptic depression was calculated from the amplitude difference between the 
unconditioned and conditioned fEPSPs, normalised to the amplitude of the unconditioned fEPSP. All 
recordings were performed in the presence of 20 µM tiagabine, a selective blocker of GABA neuronal 
transporter 1. 
To characterise the physiological activity of the hippocampal network, we measured the amplitude 
and duration of the Giant Depolarising Potentials (GDPs) that are spontaneously present in the 
untreated IHF. GDP duration was measured at 20% of GDP amplitude. To characterise the 
pathological network activity following the different pharmacological treatment, we measured the 
amplitude, duration and shape of abnormal events recorded extracellularly from the IHF. Event shape 
was quantified by the number of phases within each event, where 1 phase is defined as 1 change in the 
slope of the recorded trace. Amplitude and duration of abnormal events were normalised to the 
respective GDP values from the same cell. Frequency distributions of event amplitude, duration and 
shape were built for individual cells. Those were then averaged to generate mean frequency 
histograms for each parameter.  
Ionotropic GABA and glutamatergic currents underlying network events were isolated by means of 
their distinct reversal potentials while using CsGluconate internal solution. GABA and glutamate 
charge transfers for each event were then calculated from the areas of the GABAergic and 
glutamatergic currents underlying the event itself.  
Statistical analysis was performed with Kolmogorov-Smirnov (K-S), ANOVA or Student’s T tests, 
as appropriate. All values were expressed as mean ± standard error. Differences were considered 
significant when P < 0.05. 
 
Post-hoc morphological characterisation of recorded cells 
After recordings, slices were fixated overnight at 4°C in 0.1 M phosphate buffer saline (PBS) 
containing 4% paraformaldehyde and 0.9% NaCl. Slices were then rinsed in PBS, mounted on gelatin-
coated slides with an aqueous mounting medium (Gel Mount, Biomeda), and coverslipped. 
Rhodamine-filled cells were identified with an Olympus confocal microscope (Fluoview BX50WI) 
using a helium/neon laser as the excitation source (543 nm) and an emission filter band pass (560nm). 
Images were taken with a digital camera (ORCA-ER, Hamamatsu). Cells were classified as either 
pyramidal neurons or interneurons on the basis of their morphology and axonal projections. 
Electrophysiological data from interneurons were discarded. 
 
Drug delivery 
Drugs were diluted from stock solutions into freshly prepared ACSF immediately before the 
experiment. Drugs used in this study were: Baclofen (Sigma), 6-cyano-7-nitroquinoxaline-2,3-dione 
(CNQX; Tocris), D(-)2-amino-5-phosphovaleric acid (D-AP5; Tocris), P-3-aminopropyl-P-
diethoxymethyl phosphoric acid (CGP35348, Novartis, Basel), tiagabine (Novo Nordisk, Denmark). 
 RESULTS 
Impairing GABAB receptor-mediated presynaptic inhibition 
Our working hypothesis was that, during epileptiform activity, the sustained exposure of GABAB 
receptors (GABABRs) to elevated quantities of endogenous GABA could impair GABABR-mediated 
presynaptic inhibition of GABA release (GABA auto-inhibition). Such functional loss would then 
increase hyperexcitability and induce spontaneous pathological discharges in the newborn rat 
hippocampus. 
To test this idea, we first investigated whether ictal-like discharges (ILDs) released enough GABA 
to impair GABA auto-inhibition. ILDs were induced by application of 8.5 to 10 mM K (9.1±0.9 min, 
range 8-10 min) to either hippocampal slices or the intact hippocampal formation (IHF). We chose this 
acute model of epilepsy because elevation of [K]o occurs during seizures and contributes to their 
generation (Freund et al., 1990;Jensen & Yaari, 1997). High K induced interictal-like activity 
followed by ILDs lasting 10-20 sec in slices, and 40-120 sec in the IHF (Fig. 1A). ILDs always started 
with tonic oscillations at 10-20 Hz and ended with clonic bursts occurring at 1-2 Hz (Fig 1A). In most 
cases, an intermediate phase of tonico-clonic bursts at variable frequency could also be observed (Fig 
1A). Paired extracellular field recordings from the stratum radiatum, and whole cell recordings from 
CA3 pyramidal neurons demonstrated that GABA was continuously released over tens of seconds 
before and during ILDs in the IHF (Fig. 1A, upper trace). These are therefore ideal conditions for 
inducing a functional impairment of GABA auto-inhibition, since GABAB receptors are exposed to a 
sustained and intense activation during each discharge.  
 
Paired-pulse depression and heterosynaptic depression as indexes of efficacy of GABABR-
mediated presynaptic inhibition  
Paired-pulse depression at GABAergic synapses (PPD) (Davies et al., 1990) and heterosynaptic 
depression at glutamatergic synapses (Chandler et al., 2003) were used to monitor the efficacy of 
presynaptic GABABR-mediated inhibition in hippocampal slices.  
Both PPD and heterosynaptic depression depended upon GABAB receptor activation, as they were 
severely reduced by the selective GABABR antagonist, CGP35348. As shown in Fig 1B, average PPD 
was reduced from 35±6% (n=6) in control conditions to 7±2% in the presence of 500 µM CGP35348 
(n=6, P<0.005). Similarly, heterosynaptic depression was reduced from 35±3% to 12±3% in the 
presence of the GABABR antagonist (Fig. 1C). Both PPD and heterosynaptic depression were fully 
restored following CGP35348 washout. These results indicate that both PPD and heterosynaptic 
depression rely upon activation of presynaptic GABAB receptors in our experimental conditions. The 
functional impairment of presynaptic GABABR-mediated inhibition should therefore result in a 
reduction of both PPD and heterosynaptic depression.  
In a previous work (Tosetti et al., 2004), we showed that, among the different GABAB receptor-
mediated responses, only the presynaptic inhibition of GABA release was impaired after a prolonged 
application of baclofen. We confirmed this result by measuring PPD and heterosynaptic depression 
before and after a 5 min application of 100 µM baclofen, a GABABR agonist. While in the bath, 
baclofen induced a decrease in the probability of GABA release, resulting in a reduction of the 1st 
pulse amplitude (Fig. 2A, left panel), and a switch from depression to facilitation (control: 26±5%; 
during baclofen: -28±16%; n=6, P<0.005) (Fig. 2A control, during baclofen). Interestingly, PPD did 
not recover once baclofen was washed off, and it was still absent (-1±2%) 20 min after removal of the 
agonist (n=6, P<0.005) (Fig 2A, after baclofen).  This could not be accounted for by an incomplete 
baclofen washout, since the amplitude of the first pulse recovered to pre-baclofen values (Fig. 2A, left 
panel) and the facilitation disappeared (Fig. 2A, right panel). These results therefore suggest a 
baclofen-induced loss of GABA auto-inhibition. 
In contrast, heterosynaptic depression recovered to control values after baclofen washout (Fig. 2B, 
wash). Heterosynaptic depression was 36±2% in control conditions, 4±4% during, and 51±9% after 
baclofen application (n=6, Fig. 2B). Baclofen therefore did not impair GABABRs on glutamate fibers.  
In conclusion, these results confirm that sustained activation of GABABRs results in a selective 
decrease in the efficacy of presynaptic GABABR-mediated inhibition of GABA release. These results 
also show that PPD and heterosynaptic depression can be used as indexes of functional impairment of 
GABABR-mediated presynaptic inhibition in conditions of conserved GABA uptake and release 
probability (Roepstorff & Lambert, 1994). 
 
ILD-induced release of GABA impairs GABA auto-inhibition 
We next investigated whether endogenous GABA released during ILDs could impair GABA auto-
inhibition in hippocampal slices. 6 ILDs were induced via an 8-10 min application of 10 mM K 
(induction phase), as described above. We measured PPD and heterosynaptic depression before and 
following the induction phase, and found that only PPD was severely reduced with respect to control 
(Fig. 3). Average PPD was decreased from 34±4% in control conditions to 8±3% after K treatment 
(n=8; P<0.001; Fig. 3A). It should be noted that the amount of residual PPD after K treatment is 
consistent with the amount of GABABR-independent PPD measured in the presence of CGP35348. In 
contrast, average heterosynaptic depression did not significantly differ before (33±3; Fig. 3B, Control) 
and after the induction phase (43±9%, n=7; Fig. 3B, After high K). Thus, in agreement with the results 
of the baclofen treatment, high K treatment selectively affected GABA auto-inhibition. 
Although a decreased PPD is consistent with the functional impairment of presynaptic GABABR 
signalling, other factors may contribute to it. In fact, PPD depends also on GABA release probability 
and uptake (Roepstorff & Lambert, 1994). A decreased GABA release probability was unlikely since 
the amplitude of the GABAA postsynaptic current evoked by the 1st stimulus (1st GABA-PSC, see 
stimulating protocol in Fig 1B) was preserved before and after high K treatment (Fig. 3A, left panel). 
In agreement with this, the coefficient of variation of the 1st GABA-PSC amplitude (CVA) did not 
significantly differ before (0.13±0.02) and after high K treatment (0.14±0.03; n=8, P>0.3). Thus, the 
PPD loss cannot be accounted for by a decreased probability of GABA release. In control conditions, 
the CVA of the 2nd GABA-PSC was much higher than that of the 1st (0.41±0.1, P<0.01), in agreement 
with a reduced probability of release following GABABR activation. However, such value decreased 
significantly after high K treatment (0.18±0.04, P<0.01), as expected after a loss of GABA auto-
inhibition.  
We next tested the possibility that PPD loss was due to ILDs reducing neuronal GABA uptake. 
PPD was measured in the presence of 20 µM tiagabine, a selective blocker of GABA neuronal 
transporter 1 (Andersen et al., 1993), both before and after ILDs. PPD in tiagabine was 48±2% before 
and 8±4% after high K treatment (n=9; P<0.001; data not shown). ILDs therefore significantly 
reduced PPD even in the absence of functional neuronal GABA transporters, ruling out an impaired 
neuronal GABA uptake as the cause for PPD loss. 
Since neither GABA uptake nor the probability of GABA release were affected by ILDs, functional 
impairment of presynaptic GABABR signalling is the most likely cause of high K-induced PPD loss. 
To confirm such conclusion, we tested whether PPD loss required the activation of GABABR by co-
applying 500 µM CGP35348 during the high K induction phase. Interestingly, no PPD loss was 
observed after the high K+CGP35348 treatment (Fig. 4A). Average PPD was 27±2%, not significantly 
different from that measured in control conditions, 27±4% (P>0.6; n=9). Thus, these results show that 
activation of GABABRs by endogenous GABA is required to induce PPD loss. 
We next investigated whether the pattern of GABABR activation played an important in the 
impairment of GABA auto-inhibition. Co-applying 40 µM APV + 10 µM CNQX during the high K 
induction phase eliminated ILDs, leaving only shorter (500 ms) GABAergic bursts at 0.8 Hz (Fig 4B). 
Such discharges, which are reminiscent of Giant Depolarising Potentials (GDPs), release sufficient 
endogenous GABA to activate GABABRs (McLean et al., 1996), but are probably too short to 
functionally impair GABABR-mediated signalling. Indeed, GABABRs are functional in the presence 
of GDPs in physiological conditions (McLean et al., 1996). Interestingly, PPD was not significantly 
different before (32±7%) and after K+CNQX+APV (42±12%; n=6; P>0.05; Fig 4C). Thus, the 
intermittent activation of GABABRs does not have any effect on PPD. These results show that it is not 
GABABR activation per se, but sustained GABABR activation that is responsible for decreasing PPD.  
In conclusion, our results show that endogenous GABA released during epileptiform activity can 
induce the functional impairment of GABA auto-inhibition in the newborn hippocampus. This effect 
requires a sustained GABA release. Intermittent, short GABAergic discharges mimicking 
physiological GDPs are ineffective. 
 ILD-induced functional impairment of GABA auto-inhibition modifies network activity in 
hippocampal slices 
Our next goal was to investigate the acute and long-term consequences of a reduced GABA auto-
inhibition on the immature hippocampal network. GDPs, the giant depolarising potentials, constitute 
the hallmark of early hippocampal network activity (Ben-Ari et al., 1997). In hippocampal slices, 
GDP duration was increased by 44±8% following 6 high K-induced ILDs (Fig. 5, after high K). 
Average GDP width (measured at 20% of GDP amplitude) increased from 300±14 ms in control 
conditions to 432±20 ms after ILDs (n=6; P<0.01). Such increase is consistent with a functional loss 
of GABABR-mediated presynaptic inhibition, since previous work demonstrated that GABABR 
activation is required for GDP termination (Tosetti et al., 2004). 
We next confirmed that the increased GDP duration depended on GABABR activation by applying 
500 µM CGP35348 during the high K induction phase. Such treatment indeed prevented the increase 
in GDP width (control: 295±17 ms; after high K+CGP35348: 326±23 ms; n=6; P>0.2) (Fig. 5, after 
high K+CGP35348). These results indicate that GABABR activation is required to increase GDP 
duration, and support the idea that ILD-induced impairment of GABA auto-inhibition accounts for the 
majority of the observed increase in GDP width. An alternative approach to the same question was to 
induce ILDs via the application of 500 µM CGP35348 alone (without elevating extracellular K). In 
fact, by blocking GABAB receptors, saturating concentrations of CGP35348 transformed spontaneous 
GDPs into ILDs (McLean et al., 1996;Tosetti et al., 2004). This strategy had the dual advantage of 
generating a pattern of GABA release similar to that induced by high K (see Methods) while 
preserving GABAB receptor function after the induction phase. CGP35348-induced ILDs did not 
affect GDP duration, which passed from 289±27 ms to 316±30 ms after treatment (P>0.1; Fig 5, after 
CGP35348). 
We finally investigated the effects on GDP duration of a pattern of GABA release unable to impair 
GABA auto-inhibition. The short, frequent GABAergic bursts generated by the co-application of high 
K and 10 µM CNQX+40 µM APV (see previous chapter and Fig. 4B) did not significantly increase 
GDP width, which was 312±49 ms in control conditions and 335±44 ms after treatment (n=8; P>0.5). 
Thus, GABABR activation by endogenous GABA could not per se increase GDP width, unless it was 
long enough to impair GABA auto-inhibition. It is therefore the ILD-induced decrease of GABA auto-
inhibition that is responsible for increasing GDP duration. 
To further support this conclusion, we tested the effect on GDP width of a 5 min application of 100 
µM baclofen, a treatment known to impair GABA
 
auto-inhibition (Fig. 2) (Tosetti et al., 2004). As 
expected, GDP duration after baclofen treatment was significantly increased by 50±8%, from 275±8 
ms to 410±18 ms (n=8, P<0.001). Interestingly, this increase is not significantly different from that 
measured after high K treatment (P>0.4; Fig 5A). 
In conclusion, our results indicate that ILD-induced GABA release can increase GDP width and 
modify the spontaneous network activity by impairing GABABR-mediated GABA auto-inhibition in 
immature hippocampal slices. 
 
ILD-induced impairment of GABA auto-inhibition modifies network activity in the intact 
hippocampal formation 
Since hippocampal slices contain only a fraction of the hippocampal network, they may not ideal to 
evaluate network activity. We therefore decided to further investigate the consequence of K-induced 
ILDs using the intact hippocampal formation (IHF), a preparation that preserves the hippocampal 
circuitry (Khalilov et al., 1997).  
Network events occurring before and after high K-induced ILDs were monitored using extracellular 
field recordings of CA3 stratum radiatum. Events were then classified according to their amplitude, 
duration and shape (quantified as number of phases, see Methods). We defined as abnormal all events 
that significantly differed from GDPs in at least 2 out of the 3 above parameters. 
In control conditions, GDPs constituted the totality of network events (n=24; Fig. 6A, Control) and 
could be described as stereotyped triphasic waveforms of 21±2 µV amplitude (range 8-43 µV; n=24), 
and 484±48 ms duration (range 131-692 ms). Following ILDs, however, GDPs accounted for only 
26±4% of total events (n=24; Fig. 6A, after high K). The remaining 74±4% of network activity was 
composed of abnormal events that were never recorded in control conditions. They could be divided 
into three major classes: short oscillations, long oscillations, and interictal-like events (Fig. 6B). Short 
oscillations were characterised by relatively small amplitude (172±19% of average GDP amplitude; 
range 35-405%; n=25), intermediate duration (424±53% of average GDP duration; range 155-1161%) 
and intermediate number of phases (8.0±0.8 phases; range 2-15; GDPs=3 phases). Long oscillations 
not only displayed longer duration (3907±797% of average GDP duration, range 1097-9658%; n=10), 
but also larger amplitude (942±334% of average GDP amplitude, range 320-3167%), and always more 
than 15 phases. Interictal-like events were mostly triphasic (average=3.2±0.2, range 2-5; n=14), with 
intermediate amplitude (478±94% of average GDP amplitude, range 103-1444%), and relatively short 
duration (196±19% of average GDP duration, range 35-438%). All three types of abnormal events 
were spontaneously present in the IHF up to at least 1 hr 30 min after the induction phase. 
Simultaneous patch clamp and field recordings of the IHF were used to characterise the 
conductances underlying both GDPs and abnormal events (Fig. 6B). As previously reported, control 
GDPs were mainly driven by GABAergic currents (Ben-Ari et al., 1989;Khazipov et al., 1997). Their 
average GABA/glutamate charge transfer ratio was 16±3 (n=10), indicating that ionotropic 
glutamatergic currents accounted for only 6.25% of total GDP current. Abnormal waveforms, 
however, were driven by sizeable amounts of both GABAergic and glutamatergic currents. Their 
average GABA/glutamate charge transfer ratio was 2.9±0.4 (n=11), indicating that ionotropic 
glutamatergic currents represented approximately 34% of the total event current. Thus, GDPs and 
abnormal waveforms constitute distinct events.  
In addition to releasing endogenous GABA and impairing the GABABR-dependent response, high 
K-induced ILDs also released large quantities of glutamate (Rutecki et al., 1985). Strong glutamate 
release could induce several forms of plasticity that could contribute to the observed changes in 
network activity (Ben-Ari & Gho, 1988). To identify which type of abnormal event depended upon the 
functional loss of GABA auto-inhibition, we prevented GABABR activation during sustained GABA 
release with the application of 500 µM CGP35348. This resulted in the recovery of most of the 
spontaneous GDP activity (70±8% of total events, n=12; Fig. 6A, after high K + CGP). The remaining 
30% of events consisted exclusively of interictal-like waveforms. These results suggest that a 
decreased GABA auto-inhibition is required for the appearance of both long and short oscillations, but 
not interictal-like events in the immature hippocampus. 
Fig. 7 shows frequency distributions of abnormal event properties (duration, shape, and amplitude) 
measured after high K alone or high K+500 µM CGP3534 (n=24; for histogram values see Table 1). 
Superposed rectangles highlight properties whose frequency did not significantly differ in the presence 
or absence of GABABR activation.  Interestingly, the duration, shape, and amplitude values that were 
independent of GABABR activation well matched the properties of interictal-like events. These results 
confirm that preserving GABABR-mediated signalling prevented the appearance of long and short 
oscillations.  
If long and short oscillations are consequences of an impaired GABA auto-inhibition, treatments 
leading to a partial loss of function of GABABRs should trigger similar discharges. To test such 
hypothesis, we reduced GABABR-mediated signalling by applying non-saturating doses of 
CGP35348. Indeed, long and short oscillations strikingly similar to those recorded after high K-
induced ILD could be recorded during the application of 100 µM CGP35348 (Fig. 8A). CGP35348-
driven events were mediated by both GABAergic and glutamatergic ionotropic currents (Fig. 8A). 
Their GABA/glutamate charge transfer ratio was 3.4±0.8 (n=6), a value not significantly different 
from that of K-induced oscillations. Even more striking, the type and frequency of events recorded in 
CGP35348 and after high K-induced ILDs closely matched. After high K treatment, GDPs accounted 
for 27±3% of total events, short oscillations for 57±5%, and long oscillations for 5±2% (Fig. 8B). 
Similarly, during 100 µM CGP35348, 32±3% of the events were GDPs, 63±3% were short 
oscillations, and 5±1% were long oscillations (Fig. 8B). Interestingly, interictal-like events were not 
present during CGP application (Fig. 8B), in agreement with the idea of these events being a non-
specific effect of ILDs rather then a consequence of impairing GABA
 
auto-inhibition. 
In conclusion, the partial block of GABAB receptors induces the appearance of abnormal events 
that are qualitatively and quantitatively similar to those recorded after high K-induced ILDs. These 
results indicate that ILD-induced GABA release impairs GABA auto-inhibition and triggers the onset 
of abnormal short and long oscillations in the immature hippocampus. 
 
  
   
 DISCUSSION  
Our study focused on the functional consequences of acute epileptiform activity (ictal-like 
discharges, ILDs) on presynaptic GABABR-mediated signalling and network activity in the 
developing rat hippocampus. The central results were: 1) endogenous GABA release could impair 
GABABR-mediated presynaptic inhibition of GABAergic terminals (GABA auto-inhibition); 2) ILDs, 
but not physiological GDPs, provided the sustained GABA release required to induce such 
impairment; 3) the ILD-dependent loss of GABA auto-inhibition modified the spontaneous network 
activity and induced the onset of abnormal discharges, possibly contributing to post-seizure plasticity 
of the developing hippocampus. 
 
Endogenous GABA impairs GABA auto-inhibition 
We have demonstrated that high K-induced epileptiform activity can significantly reduce paired 
pulse depression (PPD) in the CA3 region of the developing rat hippocampus. PPD loss occurred after 
as few as 6 ILDs. Interestingly, a similar decrease in PPD could be observed in the CA1 region and in 
dentate gyrus granule cells after kindling (Wu & Leung, 1997;Buhl et al., 1996).  
How does such functional loss occur? Our data indicate that a sustained release of endogenous 
GABA during ILDs induces a PPD loss that is the consequence of an impaired GABA auto-inhibition.  
To support this hypothesis, we showed that activation of GABABRs during high K-induced ILDs was 
required to induce the PPD loss since: i) the application of the specific GABABR antagonist CGP 
35348 during the induction phase prevented it and ii) a 5 min baclofen application induced a similar 
PPD loss. We also proved that GABABR activation needed to be long-lasting in order to induce the 
PPD loss. In fact, PPD was not reduced when the pattern of GABABR activation was changed from 
sustained (during ILDs) to intermittent (during GDP-like activity). Finally, we showed that other 
mechanisms potentially able to induce PPD loss, like a decreased probability of GABA release or an 
increased GABA uptake (Roepstorff & Lambert, 1994), were not involved.  Altogether, these 
observations indicate that, in the newborn hippocampus, GABA released during ILDs impairs 
presynaptic GABABR-mediated inhibition, leading to PPD loss.  
The mechanism leading to the functional impairment of presynaptic GABABR-mediated inhibition 
is presently unknown. The simplest explanation is possibly that the release of endogenous GABA is 
sufficient to induce a conformational change of the GABAB receptor, leading to a desensitized state 
insensitive to the agonist. For example, the impaired GABA auto-inhibition could result from 
uncoupling to the effectors via agonist induced dephosphorylation of the GABAB receptors (Couve et 
al., 2002). Alternatively, it could result from phosphorylation by G-protein receptor kinases (GRKs) 
which, through the binding of β-arrestins, target the G-protein-coupled receptors for endocytosis (Tsao 
& von Zastrow, 2000;Carman & Benovic, 1998;Ferguson et al., 1998). Independently of the 
mechanism involved, the present study provides the first demonstration that endogenous GABA can 
impair GABABR-mediated inhibition and reveals one functional context where this occurs: during 
epileptiform activity. 
 
Functional consequences of ILD-induced impairment of GABA auto-inhibition 
We have shown that the ILD-induced functional loss of GABA auto-inhibition increased the 
duration of physiological Giant Depolarising Potentials (GDPs) and triggered pathological network 
oscillations in the intact hippocampus. In fact, procedures that prevented such impairment (co-
application of CGP35348 or CNQX+APV during the high K induction phase) also prevented 
alterations of network activity. Furthermore, procedures that induced (bath application of baclofen) or 
simply mimicked impairment (non-saturating concentrations of CGP35348) triggered similar 
abnormal oscillations and increased GDP duration.  
These results are consistent with previous studies reporting the fundamental role of GABABRs in 
preventing excessive hippocampal excitability during development. In fact, during the first postnatal 
week, the synchronous activation of GABAergic interneurones triggers depolarising GABAAR-
mediated currents and contributes to spontaneous network discharges called Giant Depolarising 
Potentials (GDPs) (Cherubini et al., 1991). However, once released, GABA also acts on presynaptic 
GABABRs, limiting further GABA release and effectively leading to GDP termination (McLean et al., 
1996). Impairing GABABR function at this age prevents GDP termination, transforming GDPs into 
long epileptiform discharges (Tosetti et al., 2004). In agreement with these findings, our present data 
show that ILDs impair GABA auto-inhibition and decrease the inhibitory control exerted by 
endogenous GABA on the network activity. As a direct consequence, the hippocampal network 
develops a situation of hyperexcitability, revealed by the presence of longer GDPs, and abnormal long 
and short oscillations.  
In the hippocampus, GABABRs are ubiquitously located at both postsynaptic and presynaptic sites 
on both GABAergic and glutamatergic neurons. Thus, ILDs can potentially impair the responses of 
distinct pools of GABABRs, producing complex effects on the hippocampal network. The present 
results show that GABABRs on glutamatergic terminals, in contrast to those on GABAergic terminals, 
are not impaired following high potassium exposure.  
We have previously shown that bath application of saturating concentration of baclofen does not 
impair postsynaptic GABABRs on pyramidal neurons (Tosetti et al., 2004). Considering the low 
number of ILDs used to induce such functional impairment, we think unlikely that the postsynaptic 
GABABR-mediated control of excitability was affected in the present study. However, a recent study 
(Wetherington & Lambert, 2002) reported that both pre and postsynaptic GABABRs on glutamatergic 
neurons desensitised when exposed to GABA agonists for longer periods (2 to 96 hr). It is thus 
possible that a fully developed status epilepticus, allowing GABABRs to be exposed longer and to 
higher concentration of endogenous GABA, could affect additional pools of GABABR-mediated 
responses. We however predict that impairing the postsynaptic GABABR-mediated inhibition would 
contribute to aggravate hyperexcitability and favour the emergence of pathological activity. 
 
Impairment of GABA auto-inhibition as a possible ictogenic mechanism 
Our data demonstrate that ILDs induce the loss of GABABR-mediated control of GABA release in 
the neonatal hippocampus, thus triggering network hyperexcitability and the appearance of 
spontaneous pathological discharges. Among the many seizures-induced alterations that characterise 
the epileptic tissue, some can underlie or facilitate the emergence of epileptiform activity while others 
can be seen as compensatory mechanisms to prevent seizures aggravation (Morimoto et al., 2004). 
Whether GABABR activation is protective or pro-convulsive is still controversial, with effects varying 
greatly depending on the age, brain region and type of epileptiform activity (Engel, Jr., 1995;Bettler et 
al., 1998;Sutor & Luhmann, 1998;Motalli et al., 1999;Tosetti et al., 2004;Bettler et al., 2004). The 
protective role of GABABRs during development has been confirmed by the severe epileptic 
phenotype of GABAB1-deficient mice (Prosser et al., 2001;Schuler et al., 2001). In the adult, however, 
the activation of GABABRs is generally considered pro-convulsive because it limits the inhibitory 
action of GABAARs (Engel, Jr., 1995). It may thus appear contradictory to evoke a loss of presynaptic 
inhibition of GABA release as a pro-convulsive effect. It should be considered, though, that in both 
adult (Kohling et al., 2000;Fujiwara-Tsukamoto et al., 2003) and neonatal rat hippocampus (Dzhala & 
Staley, 2003), GABAA receptor activation contributes to the emergence of epileptiform activity. In the 
neonates, GABAA receptors are excitatory in physiological conditions (Cherubini et al., 1991). In the 
adult system, GABAA receptors are usually inhibitory, but the intracellular accumulation of Cl- ions 
during sustained GABAAR activation (i.e. ILDs) can switch GABAAR-mediated synaptic responses 
from hyperpolarising to depolarising, favouring network hyperexcitability (Staley et al., 1995;Kaila et 
al., 1997). Thus, the impairment of GABA auto-inhibition is likely to favour the emergence of 
pathological activity in both immature and adult animals. Several plastic changes occurring after 
seizures facilitate the onset of chronic epileptic activity (Morimoto et al., 2004). Our data provide, 
however, the first evidence that GABABRs may contribute to post-seizure plasticity and remodelling. 
 
It is possible that seizure-induced loss of GABA auto-inhibition contributes to the long-term 
hyperexcitability observed in epileptic tissue. Several studies reported a functional loss of GABABR-
mediated inhibition (Mangan & Lothman, 1996;Haas et al., 1996;Chandler et al., 2003;Wu & Leung, 
1997) and a decrease in the number of GABABRs after intense epileptic activity in adult models of 
chronic epilepsy (Chandler et al., 2003;Straessle et al., 2003;Kokaia & Kokaia, 2001). However, the 
mechanisms underlying the long-term impairment of GABABR-mediated inhibition are not known. 
Our data raise the interesting possibility that seizure-induced GABA release contributes to the reduced 
number of GABABRs observed in chronic epileptic tissue. Indeed, the activity-dependent impairment 
of most G-protein-coupled receptors is mediated by phosphorylation followed by receptor 
internalisation (Tsao & von Zastrow, 2000). It is tempting to speculate that a prolonged GABABR 
activation, initially induced by ictal activity and later maintained by pathological discharges, leads to 
receptor internalisation and the long-term decrease in the number of functional GABABRs. 
Our present results indicate that the functional loss of GABA auto-inhibition is a consequence of 
ILDs. However, a sustained release of endogenous GABA always precedes the actual development of 
the ILD, as well documented in Fig. 1A. It is possible, although speculative, that functional 
impairment of GABABR-mediated GABA auto-inhibition occurs during such release. If this is the 
case, the reduced control of GABA release might not be simply a consequence of ILDs, but could play 
a role in the generation of pathological discharges. 
 
Conclusion  
In the neonatal hippocampus, during physiological activity, i.e. GDPs, GABABR signalling is 
recruited to limit the release of excitatory GABA. Here we show that, during epileptiform activity, an 
excessive release of GABA impairs such protective mechanism, leading to aggravation of 
hyperexcitability and appearance of spontaneous pathological discharges. The ILD-dependent 
impairment of GABA auto-inhibition may thus contribute to the pro-convulsive plastic changes that 
characterise chronic epileptic tissues. 
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  FIGURE LEGENDS 
Figure 1: Induction and quantification of functional impairment of GABA auto-inhibition. 
A. Paired whole-cell (top trace) and field (middle trace) recordings of an intact hippocampal 
formation (IHF) showing the GABAergic current underlying a K-induced ictal-like discharge (ILD). 
The GABAergic current was isolated using a combination of voltage (+10 mV) and ionic conditions 
(CsGluconate patch solution). Note the continuous release of endogenous GABA over several 
seconds. The tonic, tonico-clonic and clonic phases of the ILD are shown at an expanded time scale 
(bottom traces). B. Left: Whole-cell GABAA currents from a CA3 pyramidal neuron showing paired-
pulse depression of GABA release (PPD) before (control), during (during CGP35348, grey trace) and 
after (wash) application of 500 µM CGP35348 in hippocampal slices. Stimulating protocol is shown 
above traces. Right: average PPD before (white bar), during (grey bar) and after (black bar) 
application of 500 µM CGP35348. Note that PPD is strongly reduced when GABAB receptors are 
blocked. GABAA currents were isolated in the presence of 10 µM CNQX and 40 µM APV C. Left: 
glutamatergic field EPSPs from CA3 stratum radiatum showing heterosynaptic depression of 
glutamate release before (control), during (during CGP 35348, grey trace) and after (wash) application 
of 500 µM CGP35348 in hippocampal slices. Stimulating protocol is shown above traces. Right: 
average heterosynaptic depression before (white bar), during (dark grey bar) and after (black bar) 
application of 500 µM CGP35348.  
Asterisks indicate statistical difference with P<0.005. 
 
Figure 2: Selective impairment of GABA auto-inhibition by baclofen  
A. Left: Whole-cell recordings showing PPD before (control), during (during baclofen) and after 
(after baclofen, dark grey trace) application of 100 µM baclofen in hippocampal slices. Right: average 
PPD before (white bar), during (black bar) and after (dark grey bar) a 5 min application of 100 µM 
baclofen. Note that PPD is lost following baclofen-induced functional impairment of the GABABR-
mediated response. GABAA currents were isolated in the presence of 10 µM CNQX and 40 µM APV 
B. Left: Field recordings from CA3 stratum radiatum showing heterosynaptic depression of glutamate 
release before (control), during (during baclofen) and after (after baclofen, grey trace) application of 
100 µM baclofen in hippocampal slices. Right: average heterosynaptic depression before (white bar), 
during (black bar) and after (grey bar) a 5 min application of 100 µM baclofen. Note that no 
functional loss of heterosynaptic depression could be recorded after baclofen treatment.  
Asterisks indicate statistical difference with P<0.005. 
 
Figure 3: Selective impairment of GABA auto-inhibition by endogenous GABA  
A: Left: Traces show PPD before (control) and after (after high K) high K-induced ictal-like 
discharges (ILDs). GABAA currents were isolated in the presence of 10 µM CNQX and 40 µM APV. 
Right: Average PPD before (control) and after ILDs (after high K). PPD is significantly reduced after 
ILDs. B. Left: Field recordings from CA3 stratum radiatum showing heterosynaptic depression of 
glutamate release before (control), and after ILDs (after high K) in hippocampal slices. Right: average 
heterosynaptic depression before (white bar), and after (grey bar) high K treatment. No functional loss 
of heterosynaptic depression could be recorded after K-induced ILDs. 
Asterisks indicate statistical difference with P<0.005. 
 
Figure 4: Sustained release of endogenous GABA impairs GABA auto-inhibition 
A. Left: Whole-cell recordings of CA3 pyramidal neuron showing PPD before (control) and after 
10 mM K + 500 µM CGP35348 treatment. Preventing GABAB receptor activation during ILDs 
avoided PPD loss. Right: Average PPD before (control) and after 10 mM K+500 µM CGP35348 
treatment. GABAA currents were pharmacologically isolated using 10 µM CNQX+40 µM APV. B. 
Whole-cell recordings from two CA3 pyramidal neurons in hippocampal slices. ILDs are present in 10 
mM K (High K) but not in 10 mM K + 10 µM CNQX + 40 µM APV (High K+CNQX+APV), where 
only short, GDP-like GABAergic discharges can be observed. Holding potential: -65 mV. C. Average 
PPD before (control) and after 10 mM K + 10 µM CNQX + 40 µM APV (High K+CNQX+APV). 
Asterisks indicate statistical difference with P<0.005. 
 
Figure 5: Impairing GABA auto-inhibition increases GDP width in hippocampal slices. 
A. Voltage-clamp recordings showing GDP currents before (Control) and after the indicated 
treatments. Each trace is the mean of 15 events. Vh=-65 mV. B. Cumulative distribution of GDP 
duration before (Control) and after the indicated treatments. Note the significant increase in GDP 
duration following high K treatment. All recordings are from CA3 pyramidal neurons in acute 
hippocampal slices. 
 
Figure 6: Impairing GABA auto-inhibition induces the appearance of abnormal discharges in 
the intact hippocampus. 
A. Distribution of normal (GDPs) and abnormal events recorded from the intact hippocampal 
formation (IHF) in the presence (after high K) and absence (after high K+CGP35348) of GABABR 
activation. B. Extracellular (Field) and intracellular (Whole cell) recordings of GDPs and abnormal 
events (short oscillations, long oscillations, interictal-like) present in the IHF after high K treatment. 
Glutamatergic and GABAergic currents were isolated at the indicated potentials by means of a 
CsGluconate patch solution. The field electrode was positioned in the stratum radiatum. Whole cell 
currents were recorded from CA3 pyramidal neurons in the voltage clamp configuration.  
 
Figure 7: Properties of abnormal events. 
Frequency distributions of abnormal event properties (duration, amplitude and shape) in the 
presence (after high K) and absence (after high K+CGP35348) of sustained GABABR activation. 
Event amplitude and duration were normalised to control GDP values. Shape of events was expressed 
as number of phases, where 1 phase corresponded to 1 slope change in the trace. Note that the only 
values that do not significantly differ in the presence or absence of GABABR activation perfectly 
describe the properties of interictal-like discharges. Asterisks indicate statistical difference with 
P<0.005.  
 
Figure 8: Partial pharmacological block of GABABRs induces short and long oscillations. 
A. Extracellular (Field) and intracellular (Whole cell) recordings of GDPs, long and short 
oscillations present in an IHF during a non-saturating application of CGP35348 (100 µM). Recording 
conditions were the same as in Fig. 4B. B. Frequency distributions of normal (GDPs) and abnormal 
events recorded from an IHF during 100 µM CGP35348 (white bars), and after high K treatment 
(black bars). Note that the distributions are not significantly different, with the exception of interictal-
like discharges, which are absent during CGP treatment.  
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Table 1. Properties of pathological events occurring after ILDs in the presence (after high K) 
and absence (after high K + CGP35348) of desensitisation of GABA auto-inhibition. Table values 
represent the % of total events having the specified duration, amplitude or shape. Amplitude and 
duration bins are expressed as % of control GDP values. Asterisks indicate a statistically significant 
reduction (P<0.05). 
 
 after high K 
(%) 
after high K + CGP 
(%) 
 
duration   
<100% 6.0±4.1 3.9±2.7 
100-200% 16.1±5.5 16.9±7.1 
200-300% 31.7±8.0 5.2±3.8 * 
300-400% 8.7±4.7 1.6±1.6 * 
400-1000% 4.9±3.0 1.9±1.9 * 
>1000% 10.7±0.1 – 
   
amplitude   
<100% 4.6±2.8 – 
100-200% 18.0±6.6 3.6±2.2 * 
200-300% 8.3±4.7 1.5±1.5 * 
300-500% 17.4±6.2 17.6±6.8 
500-1000% 14.6±5.2 3.1±2.1 * 
>1000% 13.0±6.0 3.6±3.6 * 
   
phases   
2 1.6±1.2 1.6±1.6 
3 18.9±6.8 19.2±7.0 
4 19.3±6.2 6.6±3.8 * 
5 10.6±4.6 2.1±2.1 * 
6 7.0±3.9 – 
7 to 15 10.8±4.2 – 
>15 13.0±5.3 – 
 
 
 
 
